#$%^&*AU2013205795A120130523.pdf#####ABSTRACT The invention relates to the treatment of demyelinating disorder, e.g. multiple sclerosis, using a soluble lymphotoxin receptor beta receptor (LTPR) as an inhibitor of the lymphotoxin pathway.1/6 Eo 0 ii! m= AUL4 00-